Randall J. Bateman, MD
Randall J. Bateman, MD, Charles F. and Joanne Knight Distinguished Professor of Neurology, has established himself as a pioneer of Alzheimer’s disease research by contributing fundamental discoveries into the pathogenesis of the disease and establishing a collaborative framework to make its prevention a possibility.
Among his most significant achievements are development of methods to measure the synthesis and clearance of human central nervous system proteins and a highly innovative initiative to conduct secondary prevention trials in individuals with autosomal dominant Alzheimer’s disease (ADAD).
As the director of the Dominantly Inherited Alzheimer’s Network Trials Unit (DIAN-TU), Bateman is launching the first clinical trials in autosomal dominant Alzheimer’s disease (ADAD), aiming to prevent the onset of memory impairment and dementia. Bateman led efforts to form the first pharma consortium focused on ADAD, and was granted the largest-ever Alzheimer’s Association research grant for the DIAN-TU.
Bateman treats patients with dementia at the Memory Diagnostic Center of Washington University. He is also an investigator for the Knight Alzheimer’s Disease Research Center and for the Hope Center for Neurological Disorders. He mentors numerous postdoctoral fellows, graduate students and undergraduates in his lab.
He has been recognized with the 2011 Alzheimer’s Association Zenith Fellows Award, the 2011 Alzheimer’s Research Forum Open Innovation Award and the 2012 MetLife Promising Investigator Award.
His membership in honorary societies includes the American Neurological Association and the American Society for Clinical Investigation Council. Bateman’s professional memberships include the American Academy of Neurology and the Society for Neuroscience. He serves as an editor and reviewer for many prominent scientific journals and is a sought-after lecturer nationally and internationally.
Bateman is an inventor of several pending patents and an issued patent, and the scientific co-founding member of a biotechnology company located in St. Louis.
Bateman earned his medical degree from the Case Western Reserve University School of Medicine in 2000. After a neurology residency at Barnes-Jewish Hospital, he completed a postdoctoral fellowship in the Alzheimer’s Disease Research Center in 2004, with his basic studies in the laboratory of David M. Holtzman, MD, and his clinical work with John C. Morris, MD. He joined the faculty in 2004.
The Washington University Medical Center Alumni Association is pleased to present its Resident/Fellow Alumni Achievement Award to Dr. Bateman.